A A S van den Bosch1, M Goossens2, K Bonouvrié3, B Winkens4, J G Nijhuis1, F J M E Roumen5, M M L H Wassen6. 1. Department of Obstetrics and Gynecology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, PO Box 5800, 6202, Maastricht, AZ, The Netherlands. 2. Department of Rehabilitation Research & Clinical Psychological Sciences, Maastricht University, PO Box 616, 6200, Maastricht, MD, The Netherlands. 3. The Department of Pediatrics, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Belgium. 4. Department of Methodology and Statistics, Maastricht University, PO Box 616, 6200, Maastricht, MD, The Netherlands. 5. Department of Obstetrics and Gynecology, Zuyderland Medical Center Heerlen-Sittard, PO Box 4446, 6401, Heerlen, CX, The Netherlands. 6. Department of Obstetrics and Gynecology, Zuyderland Medical Center Heerlen-Sittard, PO box 5500, 6130, Sittard, MB, The Netherlands. m.wassen@zuyderland.nl.
Abstract
INTRODUCTION: The purpose of this study was to evaluate the changes in maternal quality of life (QOL) from pregnancy to 6 weeks after delivery between routine labor epidural analgesia (EA) and pain relief on maternal request only. METHODS: \Women delivering of a singleton in cephalic presentation beyond 36 + 0 weeks' gestation were randomly allocated to EA as a routine during labor (routine EA group), or to any kind of analgesia on request only (control group). The Short Form health survey (SF-36) was used to assess women's QOL before randomization, and 6 weeks postpartum. Data were analyzed according to the intention to treat principle. RESULTS:A total of 488 women were included, and antepartum as well as postpartumSF-36 questionnaires were filled in by 356 (73.0%) women, 176 (49.4%) in the routine EA group, and 180 (50.6%) in the control group. Changes from the QOL antepartum to the QOL 6 weeks postpartum were comparable between both groups, also in the subgroup of women in the control group who gave birth without any pain medication (n = 41, 22.8%). Maternal age and the incidence of adverse events related to EA, which were both higher in the routine EA group, had no influence on the changes in QOL. Differences in request for pain relief were comparable with other studies. CONCLUSION: Routine administration of EA during labor and pain relief on maternal request only are associated with comparable changes of women's QOL antepartum to 6 weeks postpartum.
RCT Entities:
INTRODUCTION: The purpose of this study was to evaluate the changes in maternal quality of life (QOL) from pregnancy to 6 weeks after delivery between routine labor epidural analgesia (EA) and pain relief on maternal request only. METHODS: \Women delivering of a singleton in cephalic presentation beyond 36 + 0 weeks' gestation were randomly allocated to EA as a routine during labor (routine EA group), or to any kind of analgesia on request only (control group). The Short Form health survey (SF-36) was used to assess women's QOL before randomization, and 6 weeks postpartum. Data were analyzed according to the intention to treat principle. RESULTS: A total of 488 women were included, and antepartum as well as postpartum SF-36 questionnaires were filled in by 356 (73.0%) women, 176 (49.4%) in the routine EA group, and 180 (50.6%) in the control group. Changes from the QOL antepartum to the QOL 6 weeks postpartum were comparable between both groups, also in the subgroup of women in the control group who gave birth without any pain medication (n = 41, 22.8%). Maternal age and the incidence of adverse events related to EA, which were both higher in the routine EA group, had no influence on the changes in QOL. Differences in request for pain relief were comparable with other studies. CONCLUSION: Routine administration of EA during labor and pain relief on maternal request only are associated with comparable changes of women's QOL antepartum to 6 weeks postpartum.
Entities:
Keywords:
Analgesia; Childbirth; Epidural; Labor; Quality of life; Randomized trial
Authors: M M L H Wassen; L J M Smits; H C J Scheepers; M A E Marcus; J Van Neer; J G Nijhuis; F J M E Roumen Journal: BJOG Date: 2014-05-22 Impact factor: 6.531
Authors: Denise Bijlenga; Corine M Koopmans; Erwin Birnie; Ben-Willem J Mol; Joris A van der Post; Kitty W Bloemenkamp; Hubertina C Scheepers; Christine Willekes; Anneke Kwee; Marion H Heres; Erik Van Beek; Claudia A Van Meir; Marloes E Van Huizen; Maria G Van Pampus; Gouke J Bonsel Journal: Hypertens Pregnancy Date: 2011 Impact factor: 2.108
Authors: Juan Miguel Martínez-Galiano; Antonio Hernández-Martínez; Julián Rodríguez-Almagro; Miguel Delgado-Rodríguez; Ana Rubio-Alvarez; Juan Gómez-Salgado Journal: Int J Environ Res Public Health Date: 2019-01-17 Impact factor: 3.390